Loyola University Medical Center: Cardinal Bernardin Cancer Center

Maywood, Illinois 60153

0 studies enrolling now · 10 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Disease, Hodgkin, Graft Vs Host Disease, Graft-Versus-Host Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Metastatic Pancreatic Cancer, Multiple Myeloma, Myelodysplasia

Studies at this site

• A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas — Completed
• A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation — Stopped early
• A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy — Stopped early
• Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients — Stopped early
• A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma — Completed
• Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT) — Completed
• Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia — Completed
• Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy — Completed
• PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma — Completed
• A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039 — Completed